Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 3, 2003, Pages 670-676

  Khin, Ei Ei ^a   Kikkawa, Fumitaka ^a,c   Ino, Kazuhiko ^a   Kajiyama, Hiroaki ^a   Suzuki, Takahiro ^a   Shibata, Kiyosumi ^a   Tamakoshi, Koji ^a   Nagasaka, Tetsuro ^b   Mizutani, Shigehiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dipeptidyl peptidase IV; Endometrial endometrioid adenocarcinoma; Immunohistochemistry; RANTES

Indexed keywords

BROXURIDINE; DIPEPTIDYL PEPTIDASE IV; MONOCLONAL ANTIBODY; RANTES;

ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0037339805     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.169     Document Type: Article

References (25)

1. Misumi Y, Hayashi Y, Arakawa F, Ikehara Y. Genome, nucleotide, OMIM, protein molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface. Biochim Biophys Acta 1992;1131:333-6.
2. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, et al. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 1996;156:1349-55.
3. Loster K, Zeilinger K, Schuppan D, Reutter W. The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem Biophys Res Commun 1995;217:341-8.
4. Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV: conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 1998;273:7222-7.
5. Hartel S, Gossrau R, Hanski C, Reutter W. Dipeptidyl peptidase (DPP) IV in rat organs: comparison of immunohistochemistry and activity histochemistry. Histochemistry 1988;89:151-61.
6. Mizutani S, Sumi S, Narita O, Tomoda Y. Purification and properties of human placental dipeptidyl peptidase IV. Nippon Sanka Fujinka Gakkai Zasshi 1985;37:769-75.
7. Fujiwara H, Maeda M, Imai K, Fukuoka M, Yasuda K, Takakura K, et al. Human luteal cells express dipeptidyl peptidase IV on the cell surface. J Clin Endocrinol Metab 1992;75:1352-7.
8. Imai K, Maeda M, Fujiwara H, Kariya M, Takakura K, Kanzaki H, et al. Dipeptidyl peptidase IV as a differentiation marker of the human endometrial glandular cells. Hum Reprod 1992;7:1189-94.
9. Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN. A marker for neoplastic progession of human melanocyte is a cell surface ectopeptidase. J Exp Med 1993;177:1135-43.
10. Tanaka T, Umeki K, Yamamoto I, Sakamoto F, Noguchi S, Ohtaki S. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer 1995;64:326-31.
11. Bogenrieder T, Finstad CL, Freeman RH, Papandrou CN, Scher HI, Albino AP, et al. Expression and localization of aminopeptidase A, aminopeptidase N and DPPIV in benign and malignant human prostate tissue. Prostate 1997;33:225-32.
12. Ten Kate J, van den Ingh HF, Khan PM, Bosman FT. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int J Cancer 1986;37:479-85.
13. Kenny AJ, O'Hare MJ, Gusterson BA. Cell-surface peptidases as modulators of growth and differentiation. Lancet 1989;2:785-7.
14. Suzuki T, Kikkawa F, Ino K, Nagasaka T, Tamakoshi K, Mizutani S. Imbalance between neutral endopeptidase 24.11 and endothelin-1 expression in human endometrial carcinoma. Oncology 2001;60:258-67.
15. Tsuge I, Ueda R, Nishida K, Namikawa R, Seto M, Maruyama T, et al. Five antigens on human T cells detected by mouse monoclonal antibodies. Clin Exp Immunol 1984;58:444-52.
16. Wesley UV, Albino AP, Tiwari S, Houghton AN. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 1999;190:311-22.
17. Moehrle MC, Schlagenhauff BE, Klessen C, Rassner G. Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study. J Cutan Pathol 1995;22:241-7.
18. Wilson MJ, Ruhland AR, Quast BJ, Reddy PK, Ewing SL, Sinha AA. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 2000;21:220-6.
19. Ino K, Nagasaka T, Okamoto T, Uehara C, Nakazato H, Nakashima N, et al. Expression of aminopeptidase A in human gestational choriocarcinoma cell lines and tissues. Placenta 2000;21:63-72.
20. Fujimura H, Ino K, Nagasaka T, Nakashima N, Nakazato H, Kikkawa F, et al. Aminopeptidase A expression in cervical neoplasia and its relationship to neoplastic transformation and progression. Oncology 2000;58:342-52.
21. Iwata S, Morimoto C. CD26/dipeptidyl peptidase IV in context: the different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med 1999;190:301-6.
22. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, et al. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 1998;4:50-7.
23. Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 1999;59:4681-7.
24. Hornung D, Ryan IP, Chao VA, Vigne JL, Schriock ED, Taylor RN. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 1997;82:1621-8.
25. Mrowietz U, Schwenk U, Maune S, Bartels J, Kupper M, Fichtner I, et al. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 1999;79:1025-31.